Donor-Derived Tuberculosis In Three Solid Organ Transplant Recipients From The Same Donor
Abstract. Donor-derived tuberculosis (TB) is a rare complication following solid-organ transplant (SOT) and TB screening is not a current transplant prereq
#Tuberculosis
For those who think we r at a stage where we can end TB need to have a relook
TB has outlived many of our generations & for a reason- the very nature of itβs transmission is vastly misrepresented
@organicbotanic.bsky.social
@elhopkins.bsky.social
academic.oup.com/ofid/article...
13.07.2025 06:41 β π 3 π 2 π¬ 0 π 0
Neutrophils from tuberculosis patients are polarized toward pro-inflammatory and anti-inflammatory phenotypes according to the disease severity
The Editors have selected this article as a highlight of the issue.
A June #TopRead identified different subtypes of neutrophils in #tuberculosis (TB) patients, indicating that neutrophils might be promising targets for TB host-directed therapy. Learn more: ow.ly/gBgR50WiiCr.
02.07.2025 17:23 β π 1 π 1 π¬ 0 π 0
V interesting step forward in discovering generalisable / public human T cell metaclones reactive to Mycobacterium tuberculosis antigens in vivo.
Potential impact for:
π Risk stratification
π Vaccine design
Do read more details in preprint π
#IDSky #TBSky #tuberculosis #immunosky
21.04.2025 18:21 β π 2 π 3 π¬ 0 π 0
Type I interferon responses contribute to immune protection against mycobacterial infection
In @elife.bsky.social: Type I interferon responses contribute to immune protection against mycobacterial infection doi.org/10.7554/eLif...
#TBSky #IDSky #Immunosky
work led by Gillian Tomlinson with support from @mnoursad.bsky.social & @innate2adaptive.bsky.social group (1/5)
31.05.2025 12:22 β π 9 π 4 π¬ 1 π 0
Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection | Journal of Experimental Medicine | Rockefeller University Press
Broomfield et al. demonstrate that early type I interferon blockade alters CXCR3 chemokine regulation and cell location to promote an antigen-dependent CD8
#WeekendRead! #InterferonFriendOrFoe!
@benjbroom.bsky.social @groomlab.bsky.social &co show @jem.org that transient type I IFN inhibition upon LCMV infection or a mRNA vaccine boosts stem-like memory CD8 T cells by altering their location within the draining lymph node, potentiating virus protection
15.03.2025 15:03 β π 13 π 4 π¬ 0 π 0
Wonder which #innate responses in your animal models are shared with or distinct from humans? We did too! To answer, we teamed up with @mcampomd.bsky.social and the Hawn lab to compare human and murine alveolar and monocyte-derived #macrophage responses to #Mtb. (1/4)
#TBSky #ImmunoSky #NewPI x 2
11.03.2025 21:38 β π 30 π 11 π¬ 2 π 0
π¦ with @nigelcurtis.bsky.social @cvandesandt.bsky.social @juliocroda.bsky.social @tricckylab.bsky.social
....and the rest of the team not yet on Bluesky
04.02.2025 05:33 β π 3 π 1 π¬ 2 π 0
Similar Spike IgG and T cell IFN-gamma responses to COVID-19 vaccination in BCG-vaccinated and control participants
π After two doses of adenovirus-based or mRNA-based #COVID vaccine, cytokine and adaptive immune responses to #SARSCoV2 were similar between the #BCGvaccine and Control groups indicating that the specific effects of #COVID19 vaccines overcame the immunomodulatory effects of BCG. πͺ
04.02.2025 05:33 β π 1 π 0 π¬ 1 π 0
Forest plot showing lower cytokine responses to SARS-CoV-2 stimulation in BCG-vaccinated compared to control participants
π¬ Before #COVID-19 vaccination (almost a year after randomisation), healthcare workers who received #BCGVaccine had reduced cytokine responses to #SARSCoV2 compared to controls, indicating BCG-induced immunomodulation.
04.02.2025 05:33 β π 1 π 0 π¬ 1 π 0
<em>Clinical & Translational Immunology</em> | ASI Journal | Wiley Online Library
Bacille CalmetteβGuΓ©rin (BCG), the vaccine for tuberculosis, has immunomodulatory effects that may underpin its off-target effects on infectious disease risk and vaccine responses. This study used bl....
Iβm excited to share our new study of the off-target effects of #BCGVaccine on response to #SARSCoV2 & #COVID-19 vaccines. We analysed immune responses before & after COVID-19 vaccination in healthcare workers in the #BRACE RCT. ππ¦ #Immunology #IDsky #Immunosky doi.org/10.1002/cti2...
04.02.2025 05:33 β π 15 π 6 π¬ 1 π 1
SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals
The immune response to viral infection is shaped by past exposures to related virus strains, a phenomenon known as imprinting. For SARS-CoV-2, much of the population has been imprinted by a viral spike from an early strain, either through vaccination or infection during the early stages of the COVID-19 pandemic. As a consequence of this imprinting, infection with more recent SARS-CoV-2 strains primarily boosts cross-reactive antibodies elicited by the imprinting strain. Here we compare the neutralizing antibody specificities of imprinted individuals versus infants infected with a recent strain. Specifically, we use pseudovirus-based deep mutational scanning to measure how spike mutations affect neutralization by the serum antibodies of adults and children imprinted by the original vaccine versus infants with a primary infection by a XBB* variant. While the serum neutralizing activity of the imprinted individuals primarily targets the spike receptor-binding domain (RBD), serum neutralizing activity of infants only infected with XBB* mostly targets the spike N-terminal domain (NTD). In these infants, secondary exposure to the XBB* spike via vaccination shifts more of the neutralizing activity towards the RBD, although the specific RBD sites targeted are different than for imprinted adults. The dramatic differences in neutralization specificities among individuals with different exposure histories likely impact SARS-CoV-2 evolution.
### Competing Interest Statement
J.D.B. and B.D. are inventors on Fred Hutch licensed patents related to the pseudovirus deep mutational scanning technique used in this paper. J.D.B. consults for Apriori Bio, Invivyd, Pfizer, the Vaccine Company, Moderna, and GSK. B.D. consults for Moderna. HYC has consulted for Bill and Melinda Gates Foundation and Ellume, and has served on advisory boards for Vir, Merck, Roche and Abbvie. She has received research funding from Gates Ventures. M.A.S. has received research funding from Cepheid and Pfizer and has consulted for Merck.
SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals
Another paper to provide more insights into antibody responses and imprinting.
www.biorxiv.org/cont...
1/9
22.01.2025 12:38 β π 15 π 5 π¬ 1 π 0
JCI -
Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoli
Mycobacterium #tuberculosis resisters despite #HIV exhibit activated T cells and macrophages in their pulmonary alveoli www.jci.org/articles/vie... (open access) @jclinical-invest.bsky.social
22.01.2025 22:06 β π 1 π 1 π¬ 0 π 0
πβ€΅οΈ - @altmetric.com further cementing Bluesky as a platform for sharing and quantifying academic discussions. β
And, as this thread demonstrates, it's been achieved with a good dose of humour, which never goes amiss in life or academia! π
#AcademicSky #IDSky #ImmunoSky #clinmicro
03.12.2024 16:11 β π 46 π 17 π¬ 0 π 1
Hi Rod, it's great seeing the community rebuild on blue sky. Would love to be added to your immunology starter packs.
29.11.2024 22:41 β π 2 π 0 π¬ 0 π 0
Want to make beautiful scientific figures? Easy!
The NIH released a library of 2000+ free scientific illustrations called *BioArt*.
Check it out! bioart.niaid.nih.gov
#AcademicSky #PsychSciSky π§ π¦ π§ͺ
30.10.2024 09:45 β π 562 π 260 π¬ 28 π 18
Like βold Twitterβ: The scientific community finds a new home on Bluesky
After recent changes to Elon Muskβs X, a gradual migration turns into a stampede
'For scientists the network is starting to look like home. Academic institutions, scientific journals and conferences, and international organizations such as the World Health Organization have established a presence there in recent days.'
www.science.org/content/arti...
21.11.2024 05:49 β π 324 π 83 π¬ 3 π 4
Older neonates (>10 days) have stronger IFN-Ξ³ and IFN-Ξ³-inducible chemokine responses to P. falciparum in vitro #malaria #ImmunoSky
bmcimmunol.biomedcentral.com/articles/10....
19.11.2024 20:08 β π 0 π 0 π¬ 0 π 0
Psoriasis Risk With Immune Checkpoint Inhibitors
This cohort study evaluates the psoriasis risk associated with the use of immune checkpoint inhibitors among patients with cancer.
Immunomodulation is so fascinating in the way it teaches us about the role of key immune components in the careful balancing act between infection and autoimmunity risk.
Here, it's for checkpoint inhibitors and increased risk of psoriasis
#MedSky #ImmunoSky
jamanetwork.com/journals/jam...
17.11.2024 16:24 β π 38 π 6 π¬ 1 π 0
our #TBSky starter pack is up to 75 people! ππ» iβve also added in the two largest TB feeds from @gpollara.bsky.social and @tbfighters.org (thank you both!)βyou can also get good #TB content in the βpostsβ section of the starter pack
next goal: a #TBSky recurring journal club π€
go.bsky.app/Au7nuHk
16.11.2024 16:32 β π 92 π 36 π¬ 24 π 3
π©πΌβπ¬π²πΎπ¦πΊπΊπ²π¬
T(ea) cells & bad banter.
The International Cytokine & Interferon Society (ICIS ), is the premier organization promoting the field of cytokine & interferon biology across many different research disciplines, including cytokine biomarkers & cytokine therapeutics.
The International Union Against Tuberculosis and Lung Disease is a global scientific organisation working to #EndTB and improve #lunghealth. #NoTobacco #CleanAir.
Professor of Medical Microbiology @ Sydney ID, Univeristy of Sydney. Studying bad bugs and making better vaccines
Team leader Murdoch Childrenβs Research Institute (MCRI) and Honorary Senior Research Fellow at the University of Melbourne | Immunology | Virology | Influenza | COVID19 | Aging | T cells | TCRs
We're a research lab at Rockefeller University (NY) and Necker Hospital (Paris) studying human genetic and immunological determinants of infectious diseases.
https://www.hgid.org/
Associate editor Science Magazine
Immunology | Haematology | Host-pathogen interactions
Making a comeback. Hope to be in a lung near you soon! #PathogenBluesky
EFIS-IL study group.
Join us by registering here: https://bit.ly/efis_immunesexdiff
Pediatrician &
Professor of Pediatric Immunology
Human Systems Immunology
MRC LMS, Imperial College London
& Karolinska Institutet
Immunologist interested in T cells, B cells, antibodies, vaccines & global health. #StrepA #malaria Lab Head @MonashImmunol @MonashUni She/Her
https://research.monash.edu/en/persons/danika-hill
TB doc, Manhattan TB consultant @ NYC Dept of Health
NYU Clinical Asst Professor of ID @ Bellevue Hospital
Loyola Med/Peds & Stanford ID
β€οΈ: TB, ID, med ed, public health, health equity, immigrant safety/rights
Views = mine = great, & β my employers' | π³οΈβπ
Healthcare epidemiologist
Student of infection and AMR transmission
profiles.stanford.edu/jorge-salinas
infectionprevention.stanford.edu
Infectious Disease Professor (Immunocompromised Host/ Transplant ID) at Stanford University.
ID MD, currently working on stewardship programming. Currently upskilling in NTM. Previously TB-Practecal and endTB with MSF. #IDsky #TBsky #AMSsky
Epidemiology, infection
https://profiles.ucl.ac.uk/37299-tom-yates/about
Academic physician-scientist at USFMCOM. #infectiousdiseases #NTMs #immunology #ASP #MTB #Mentoring #NTDs #IDSky #TBSky π¨π»ββοΈπ©Ίππ¦
Researching macrophages and neutrophils in TB || Entomology PhD, ticks and tick-borne bacteria || macro photography and reef aquaria enthusiast || opinions my own || Northern Minnnesotan